|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies 显示文摘 | Wu E Croucher PI McKie N | 1997 | Biochem Biophys Res Commun1997，235，2： | 1 |
| 2 | 显示文摘 | Croucher PI Shipman CM Lippitt J | 2001 | Blood2001，98，： | 1 |
| 3 | Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease:evidence for decreased osteolysis,tumor burden and angiogenesis and increased survival显示文摘 | Croucher PI De Hendrik R Perry Mj | 2003 | J Bone Miner Res2003，18，3： | 1 |
| 4 | Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease显示文摘 | Croucher PI Shipman CM Camp BV | 2003 | Cancer2003，97，3： | 1 |
| 5 | Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease显示文摘 | Croucher PI Shipman CM Van Camp B | 2003 | Cancer2003，97，3： | 1 |
| 6 | Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis,tumor burden and angiogenesis, and increased survival显示文摘 | Croucher PI De Hendrik R Perry MJ | 2003 | J Bone Miner Res2003，18，3： | 1 |
| 7 | Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma显示文摘 | Croucher PI Shipman CM Lippitt J | 2001 | Blood2001，98，13： | 1 |
| 8 | Zoledronate induces apoptosis of breast cancer cells in vitro evidenee for additive and synergistic effects with taxol and tamoxifen显示文摘 | Croucher PI Coleman RE | 2000 | Proc Am Soc Clin Oncol2000，19，6： | 1 |
| 9 | Bone disease in multiple myeloma显示文摘 | Croucher PI Apperley JF | 1998 | Br J Haematol1998，103，5： | 1 |
| 10 | Zoledronic acid treatment of 5T2MM-bearing mice inhibits the devel- opment of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival 显示文摘 | Croucher PI De Hendrik R Perry M J | 2003 | J Bone Miner Res2003，18，： | 1 |
| 11 | Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies显示文摘 | Wu E Croucher PI McKie N | 1997 | Biochem Biophys Res Commun1997，235，2： | 1 |
| 12 | Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells显示文摘 | Croucher PI | 2003 | Cancer Res2003，63，： | 1 |
| 13 | ADAM-9 (MDC-9 / meltringamma) ,a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha (v)beta5 integrin 显示文摘 | Karadag A Zhou M Croucher PI | 2006 | 152006，107，8： | 1 |
| 14 | Zoledronate induces apoptosis of breast cancer ceils in vitro evidence for additive and synergistic effects with taxol and tamoxifen 显示文摘 | Jagder SP Croucher PI Coleman RE | 2000 | Proc Am Soc Clin Oncol2000，19，6： | 1 |
| 15 | Bone disease in multiple myelo- ma显示文摘 | Croucher PI Appedey JF | 1998 | Br Haematol1998，103，4： | 1 |
| 16 | Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells 显示文摘 | Holen I Croucher PI Hamdy FC | 2002 | Cancer Res2002，62，6： | 1 |
| 17 | Bone disease in multiple myeloma显示文摘 | Croucher PI Apperley JF | 1998 | Br J Haematol1998，103，4： | 1 |
| 18 | Zoledronate induces apoptosis of breast cancer cells in vitro evidence for additive and synergistic effects with taxol and tamoxifen 显示文摘 | Jagder SP Croucher PI Coleman RE | 2000 | Proc Am Soc Clin Oncol2000，19，6： | 1 |
| 19 | Bisphosphonates: pharmacology, mechanisms of action and clinical uses 显示文摘 | Russell RG Croucher PI Rogers MJ | 1999 | Osteoporos Int1999，9，2： | 1 |
| 20 | Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor, and marrow space star volume显示文摘 | Garrahan NJ Compston JE | 1996 | J Bone Miner Res1996，11，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员